Applications Now Available for ACHA's 2024 Research Grants

Posted Tuesday, Mar 26, 2024

Since launching our emerging research program in 2019, ACHA has invested more than half a million dollars to fund 18 investigations at adult congenital heart disease (ACHD) centers across the country. We are excited to build upon our commitment to unlocking new discoveries for our patient population, and are thrilled to announce today that grant applications for ACHA’s 2024 Research Awards are now available!

ACHA’s 2024 research program will continue to accept applications for early investigation and pilot studies for all ACHD disciplines. We are proud to once again offer the Meil Family Foundation Research Award for Neurocognitive Studies, which debuted in 2022, as well as the Pulmonary Vascular Disease Research Award, funded by a corporate sponsorship from Johnson & Johnson, which debuted in 2023.

Applications for all three opportunities are available by clicking below:

Applications are due June 3, 2024, and projects will start October 1, 2024. Applicants can be any type of faculty involved in ACHD: Doctor, Fellow, NP, PA, Nurse, etc.

As the only national patient advocacy organization whose research program is solely dedicated to funding ACHD studies, we are pleased to share our research priorities and why ACHA research is so important.

ACHA's Research Priorities:

  • Advancing the science and understanding of congenital heart disease in adults.
  • Cultivating a new generation of ACHD providers.
  • Collaborating with patients for better health outcomes.

Why ACHA Research Is So Important:

  • Our research program advances ACHA’s mission to empower the congenital heart disease community by advancing access to resources and specialized care that improve patient-centered outcomes.
  • Our research program embraces best practices with a peer-review model that involves both patient and medical reviewers to ensure we are funding the most critical and relevant studies.
  • We are funding research grants and projects that are important to our ACHD community.
  • We are funding studies that gather critical "proof of concept" data that is often necessary to secure private and government funding for larger studies.
  • We are committed to increasing research funding to ensure additional projects for years to come.
  • We regularly provide updates about research projects ACHA is funding to all key stakeholders.

We are so excited to continue to move forward with this critical initiative. Thank you to all who have contributed. We are also looking forward to investing in research for years to come, and we are only able to do this because of the support of our generous donors and corporate funders including the Meil Family Foundation, Johnson & Johnson, Anne Stapleton Reilly, Brad’s Heart of a Jayhawk Research Fund, Dale Amorosia Heart Fund, Heithoff Charitable Fund, Jim Wong Memorial Fund, Joseph E. Hebert, and Susan Timmins. Learn more about ACHA's Research Fund and consider donating by clicking here.

Connect with ACHA

Join us in our mission to empower the congenital heart disease community by advancing access to resources and specialized care that improve patient-centered outcomes.

Enter your name, email and state to get started. If you choose to, you can provide more information to us in the next step for more tailored communications! We'll never, for any reason, share your personal information. Already get ACHA emails? We’ve got you! You do NOT need to fill out this form.

*By sharing your information, you consent to receiving emails from ACHA.

  • {{ m }}
{{ validation.firstError('basic.FirstName') }}
{{ validation.firstError('basic.LastName') }}
{{ validation.firstError('basic.Email') }}
{{ validation.firstError('basic.State') }}
Close